Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10K Buy
47
+6
+15% +$1.5K ﹤0.01% 505
2025
Q4
$9K Sell
41
-8
-16% -$2.05K ﹤0.01% 521
2025
Q3
$13K Hold
49
﹤0.01% 429
2025
Q2
$12K Buy
49
+18
+58% +$4.29K ﹤0.01% 426
2025
Q1
$7K Hold
31
﹤0.01% 472
2024
Q4
$7K Sell
31
-1
-3% -$241 ﹤0.01% 471
2024
Q3
$7K Hold
32
﹤0.01% 456
2024
Q2
$6K Buy
32
+8
+33% +$1.62K ﹤0.01% 439
2024
Q1
$5K Buy
24
+6
+33% +$1.1K ﹤0.01% 475
2023
Q4
$3K Buy
18
+4
+29% +$615 ﹤0.01% 503
2023
Q3
$1K Buy
+14
New +$2.53K ﹤0.01% 717
2023
Q2
Sell
-2
Closed 989
2023
Q1
$0 Buy
+2
New +$434 ﹤0.01% 737

Other funds holding RMD

Avion Wealth's RMD Position: Q1 2026 in Review

Avion Wealth increased its ResMed (RMD) stake by 15% in Q1 2026, buying an estimated $1.5K and bringing the position to 47 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #505.

Avion Wealth first reported a position in RMD in Q1 2023 and has held it in 12 quarters since. The position peaked at $13K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Avion Wealth held 47 shares of ResMed worth $10K as of Q1 2026.
  • Avion Wealth bought 6 ResMed shares in Q1 2026, an estimated $1.5K.
  • ResMed made up ﹤0.01% of Avion Wealth's portfolio in Q1 2026, its #505 holding.
  • Avion Wealth first reported a position in ResMed in Q1 2023 and has held it in 12 quarters since.
  • Avion Wealth's ResMed position peaked at $13K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.